Cosmos Health (NASDAQ:COSM) has entered into a securities purchase agreement with a U.S.-based institutional investor for the issuance of up to $300 million in senior secured convertible promissory notes to support the launch of its Ethereum (ETH) digital asset treasury reserve strategy.
Strategic accumulation of ETH to enhance long-term shareholder value through increasing ETH-per-share.
The company plans to explore additional yield-generating strategies to optimize cash flow and utility from ETH holdings.